Does Hers Accept HSA/FSA? Hers vs PlexusDx (2026)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you landed here trying to figure out whether Hers accepts your HSA or FSA card, the honest answer is: yes for the medication, but Hers steers you toward reimbursement rather than swiping the card at checkout. That distinction is the entire reason this question is confusing. Below we walk the Hers HSA/FSA mechanics in plain English, then compare against how PlexusDx handles the same payment question across its Semaglutide Injection Protocol, Tirzepatide Injection Protocol, and Microdose GLP-1 Protocol. PlexusDx accepts HSA/FSA card payment at checkout where your plan permits and does not directly bill insurance — same cash-pay model, different friction profile, and pricing that starts at $129/mo flat with no membership fee.

Quick answer: Hers vs PlexusDx on HSA/FSA

Hers states that GLP-1 injectable medications and oral weight-loss medication kits are eligible for HSA and FSA reimbursement. Hers’ own guidance recommends paying with a regular credit or debit card and submitting the receipt to your plan administrator, rather than swiping an HSA/FSA card at checkout. The medication is reimbursable; the separate $149/month Hers Weight Loss Membership fee is plan-dependent. PlexusDx works on the same IRS rule book — prescription GLP-1 medication is a qualified medical expense under Publication 502 — but lets you swipe an HSA or FSA card at checkout where your plan permits, with no membership fee layered on top. Both programs are cash-pay; neither bills insurance directly. The trade you are weighing is friction, total cost, and whether genetics inform your dose before week one.

How Hers handles HSA/FSA payment in 2026

Hers publishes an HSA/FSA reimbursement page that says the full amount of your GLP-1 injectable or oral weight-loss medication kit is eligible for HSA and FSA reimbursement. The recommended pathway, per Hers, is the reimbursement route: pay with a regular credit or debit card, download your receipt from the Orders tab, and submit it to your HSA/FSA administrator. Hers also flags that direct HSA/FSA card use at checkout can trigger a receipt-verification step or be declined outright by stricter plan administrators — particularly on compounded medications. The Hers Weight Loss main page lists Wegovy® pill from $149/mo and Wegovy® pen from $199/mo on a medication-only line, with the $39 first-month / $149/mo Hers Weight Loss Membership billed separately. Hers also notes that GLP-1s are not yet available in all 50 states, so eligibility is a separate gate from payment.

How PlexusDx handles HSA/FSA card payment

PlexusDx accepts HSA and FSA card payment at checkout where your plan permits, and does not bill insurance directly. There is no separate membership fee — the price you see on each protocol page is the all-inclusive monthly price covering async (or, in five states, scheduled live) provider consultation, prescription, the compounded medication itself, and shipping. If your HSA/FSA administrator declines a particular charge for any reason, the same IRS Publication 502 reimbursement pathway is available: pay with a regular card, download the receipt from your PlexusDx account, and submit it to your administrator. The genetic test add-ons (Precision Peptide Genetic Test at $298 standalone or $99 as an add-on after your first month, and the Optimal Diet & Weight Loss Genetic Test at $298 standalone) follow the same payment rules — HSA/FSA eligibility for genetic testing depends on whether your plan administrator accepts diagnostic-purpose documentation, and we encourage you to confirm with your plan before purchase.

The IRS rule, in plain English

IRS Publication 502 treats prescription drugs prescribed by a physician to treat a specifically diagnosed medical condition as qualified medical expenses. Compounded semaglutide and compounded tirzepatide, dispensed under a valid U.S. prescription for the treatment of obesity or related conditions, fall inside that category — the same way Wegovy® and Zepbound® do. Publication 502 also addresses weight-loss programs: program or membership fees are eligible only when the program treats a specifically diagnosed disease (such as obesity, hypertension, or heart disease) and the participant has supporting documentation. That nuance is why the medication side of any GLP-1 platform is the strong part of the eligibility argument and the membership/program-fee side is where plan administrators sometimes push back. PlexusDx avoids that ambiguity by structuring every protocol as a single all-inclusive medication price — there is no separate “membership” line item to defend to an administrator.

Real annual cost: Hers vs PlexusDx with HSA/FSA factored in

For a cash-pay patient using Hers’ lowest advertised tier, the medication-only line runs $149/mo for Wegovy® pill (or $199/mo for the pen), plus the $39 first-month / $149/mo Hers Weight Loss Membership. The all-in first year on the pill plan is roughly $39 (first-month membership) + $149 × 11 (membership) + $149 × 12 (medication) = about $3,466 before any HSA/FSA reimbursement, of which the $1,788 medication portion is clearly reimbursable and the membership portion is plan-dependent. Hers cites an average 30% pre-tax savings on the medication portion based on combined state and federal tax rates. PlexusDx pricing — Microdose GLP-1 Protocol at $129/mo flat ($1,548/year), Semaglutide Injection at $149/mo ($2,148–$2,748/year), Tirzepatide Injection at $249/mo ($2,748–$3,708/year), Semaglutide Oral from $249/mo, Tirzepatide Oral at $279/mo, and GLP-Squared at $249/mo — is the all-in number, with no separate membership. The HSA/FSA-eligible portion is the entire monthly charge for the medication itself, paid with an HSA/FSA card at checkout where your plan permits.

What documentation each platform provides for your administrator

Hers will provide copies of your medical records and prescription on request through Hims Support. Hers does not permit its providers to complete third-party forms on the administrator’s letterhead, including Letter of Medical Necessity (LMN) forms — if your plan requires a formal LMN, Hers’ guidance is to bring your Hers records to your primary care provider to complete it. PlexusDx provides itemized receipts that show the prescription medication line item, your provider’s identifying information, and the dispensing pharmacy details — the documentation most plans require for substantiation. If your administrator requires a formal LMN, the practical path is the same on both platforms: take your prescription and visit notes to your established primary care provider, who is positioned to complete an LMN. None of this is unique to GLP-1 weight management — it’s how cash-pay telehealth and HSA/FSA administration interact across the entire category.

Compounded vs FDA-approved — what each platform dispenses

Hers, as of the March 26, 2026 Hims & Hers investor announcement, dispenses Novo Nordisk’s FDA-approved GLP-1s (Wegovy® pen and Wegovy® pill) on its main weight-loss path; some Hers compounded options have existed historically but the headline pricing on the public weight-loss page now points to branded Wegovy®. PlexusDx Weight Management Protocols use compounded semaglutide and compounded tirzepatide from licensed U.S. compounding pharmacies. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products — they are pharmacy-prepared formulations of the same active ingredients found in Wegovy®, Ozempic®, Mounjaro®, and Zepbound®, prescribed under U.S. compounding regulations. Both compounded and branded prescription medications can be HSA/FSA-eligible under IRS Publication 502; some plan administrators apply stricter scrutiny to compounded medications, which is one reason Hers recommends the reimbursement route over direct card use. PlexusDx’s position: swipe the HSA/FSA card at checkout where your plan permits, fall back to reimbursement if it doesn’t.

Why a genetic baseline changes the dose conversation

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor itself), GIPR rs1800437 (the headline differential-response variant), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different patterns of response to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 unique genes and 57 genetic variants across 14 health pathways — including 34 weight-management insights — and delivers results through the PlexusDx Peptide Pathways Report. The clinical purpose: anchor titration decisions to a measurable genetic baseline before week one rather than starting from a population-average schedule and adjusting based on subjective tolerability. Hers does not include genetic testing in its weight-loss program. PlexusDx offers the test at $298 standalone or $99 as an add-on after your first month on any protocol, payable by HSA/FSA card where your plan accepts diagnostic-test documentation.

Which one fits — a four-question frame

Question 1: Do you specifically want the FDA-approved branded Wegovy® product, and are you comfortable with Hers’ reimbursement-first HSA/FSA workflow plus a separate $149/mo membership fee? Hers fits. Question 2: Do you want to pay your HSA/FSA card directly at checkout for an all-in monthly price with no membership layer? Compare PlexusDx Microdose GLP-1 Protocol at $129/mo, Semaglutide Injection at $149/mo, or Tirzepatide Injection at $249/mo. Question 3: Do you want a non-injection oral path? Hers offers Wegovy® pill at $149/mo plus membership; PlexusDx offers Semaglutide Oral from $249/mo (all-in, no membership) or Tirzepatide Oral at $279/mo. Question 4: Do you want a genetic baseline informing dose and titration before the first dose? Add the Precision Peptide Genetic Test at $99 after your first PlexusDx protocol month — Hers does not offer an equivalent.

Frequently asked questions

Does PlexusDx accept HSA/FSA cards at checkout?

PlexusDx accepts HSA and FSA card payment at checkout where your plan permits. PlexusDx does not bill insurance directly. If your plan administrator declines a specific charge, you can pay with a regular card and submit the PlexusDx receipt for reimbursement under IRS Publication 502, the same way Hers recommends.

Does Hers accept HSA/FSA?

Yes. Hers states that GLP-1 injectable medications and oral weight-loss medication kits purchased through Hers are eligible for HSA and FSA reimbursement. Hers recommends paying with a regular credit or debit card and submitting the receipt for reimbursement rather than swiping an HSA/FSA card at checkout.

Is the Hers $149/month Weight Loss Membership fee HSA/FSA eligible?

It is plan-dependent. IRS rules treat weight-loss program or membership fees as eligible only when the program treats a specifically diagnosed medical condition and your plan accepts the documentation. Hers labels the medication as reimbursable but does not explicitly market the membership as eligible. PlexusDx avoids the question by charging a single all-inclusive monthly price with no separate membership.

How much can I save on a GLP-1 with HSA or FSA dollars?

Hers cites an average of 30% pre-tax savings based on combined state and federal tax rates. On a $179/month PlexusDx Semaglutide Injection plan, a 30% pre-tax rate would equate to roughly $54/month in savings on the medication line. Actual savings depend on your specific tax bracket and plan structure.

Will PlexusDx provide an itemized receipt for my HSA/FSA administrator?

Yes. PlexusDx provides itemized receipts showing the prescription medication line, provider information, and dispensing pharmacy details — the substantiation most plan administrators require. PlexusDx does not complete Letter of Medical Necessity forms on third-party administrator letterhead; if your plan requires a formal LMN, take your PlexusDx records to your established primary care provider.

Are GLP-1 medications available in every state through PlexusDx?

PlexusDx Weight Management Protocols are available in all 50 states. Five states require a scheduled live consultation rather than the standard async intake. Hers, by contrast, states that GLP-1 medications are not yet available in all 50 states — verify state availability during the Hers intake before committing.

Is compounded semaglutide HSA/FSA eligible the same way Wegovy is?

Compounded semaglutide dispensed under a valid U.S. prescription for a diagnosed medical condition meets the IRS Publication 502 definition of a qualified medical expense, the same as Wegovy®. Some plan administrators apply additional scrutiny to compounded medications and may request documentation; the underlying eligibility rule is the same. Always confirm with your administrator before purchase if you are unsure.

Does Hers Accept HSA/FSA? Hers vs PlexusDx (2026): Reimbursement, Card Payment, and What's Eligible | PlexusDx